PCM
TPTX

PenderFund Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

PenderFund Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,180
Closed -$502K – 199
2022
Q2 		$502K Buy
+5,180
New +$502K 0.14% 63